CompanyNewsHQ
The latest news from the pharmaceutical sector. Covering the latest breaking news, encompassing company news from leading pharmaceutical companies and related companies.
– If approved, marstacimab has potential to be a best-in-class treatment option among novel non-factor agents – NEW YORK–(BUSINESS WIRE)–
Read moreAt age 14, Gisela Delgado felt unwell. She thought she had the flu, but when she noticed blood in her
Read moreAt age 14, Gisela Delgado felt unwell. She thought she had the flu, but when she noticed blood in her
Read moreTHOUSAND OAKS, Calif., Nov. 23, 2020 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced the Company has provided notice to Cytokinetics of
Read moreCurrently no vaccine is available for respiratory syncytial virus (RSV) RSV-associated lower respiratory tract illnesses (LRTIs) cause significant global morbidity
Read moreEuropean Commission approves MenQuadfi®, the latest innovation in meningococcal (MenACWY) vaccination for individuals 12 months of age and older EC
Read moreTARRYTOWN, N.Y., Nov. 21, 2020 /PRNewswire/ — First treatment of any kind to have prospectively confirmed and statistically significant anti-viral
Read moreIn addition to today’s submission to the FDA, the companies have already initiated rolling submissions across the globe including in
Read more20 November 2020 07:00 GMT Four-week dosing now approved in all Imfinzi indications, reducing medical visits and improving patient convenience
Read more– The new 100 mg/mL formulation will reduce infusion time by approximately 60%, lessening the burden on patients – –
Read moreNovartis enters into exclusive worldwide license with Mesoblast to develop, commercialize and manufacture remestemcel-L for treatment of acute respiratory distress
Read moreBefore leaving port, sailors rely on meteorological data – wind force, swell, air temperature – to help them predict weather
Read morePivotal ASCEMBL study of novel, investigational STAMP inhibitor asciminib (ABL001) vs. bosutinib in CML patients previously treated with two or
Read moreFor media and investors only Issued: London UK; Philadelphia US; Geneva Switzerland GSK and Medicines for Malaria Venture (MMV) today
Read moreLORBRENA treatment resulted in 72% reduction in risk of progression or death Data also show secondary endpoint of intra-cranial response
Read moreLORBRENA treatment resulted in 72% reduction in risk of progression or death Data also show secondary endpoint of intra-cranial response
Read more19 November 2020 07:00 GMT Presentations support Calquence efficacy and tolerability with long-term follow-up in mantle cell lymphoma and pooled
Read moreTOKYO, November 19, 2020 — Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) announced the company received the Best IR Award for
Read moreNovartis signed five virtual power purchase agreements (VPPAs), which are expected to collectively add 277 megawatts of clean power to the
Read moreFive virtual power purchase agreements (VPPAs) with three developers expected to add more than 275 megawatts of clean power to
Read moreFive virtual power purchase agreements (VPPAs) with three developers expected to add more than 275 megawatts of clean power to
Read moreDUBLIN, IRELAND, Nov. 18, 2020 (GLOBE NEWSWIRE) — STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced that is
Read moreActions include Pfizer’s S. COVID-19 Immunization Pilot Program, that aims to help inform vaccine deployment and delivery logistics nationally Pfizer has been preparing
Read moreNORTH CHICAGO, Ill., Nov. 18, 2020 /PRNewswire/ — AbbVie Inc. (NYSE:ABBV) (“AbbVie“) announced today the expiration and final results of
Read more